TABLE OF CONTENTS
1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.3 OVERVIEW OF GLOBAL HEALTHCARE ANALYTICS MARKET 31
1.4 CURRENCY AND PRICING 32
1.5 LIMITATION 32
1.6 MARKETS COVERED 32
2 MARKET SEGMENTATION 35
2.1 MARKETS COVERED 35
2.2 YEARS CONSIDERED FOR THE STUDY 36
2.3 CURRENCY AND PRICING 36
2.4 RESEARCH METHODOLOGY 37
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.6 DBMR MARKET POSITION GRID 40
2.7 DBMR MARKET CHALLENGE MATRIX 42
2.8 SECONDARY SOURCES 43
2.9 ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 46
5 MARKET OVERVIEW 48
5.1 DRIVERS 50
5.1.1 GOVERNMENT INITATIVES TO ENCOURAGE USE OF ELECTRONIC HEALTH RECORDS 50
5.1.2 INTRODUCTION OF NEW SOLUTIONS AND SERVICES IN HEALTHCARE ANALYTICS 51
5.1.3 ENTRY OF BIG DATA INTO HEALTHCARE 51
5.1.4 GROWING NEED TO CURB HEALTHCARE SPENDING WITH BETTER CLINICAL OUTCOMES 52
5.2 RESTRAINT 53
5.2.1 LESS NUMBER OF SKILLED PERSONNEL 53
5.3 OPPORTUNITIES 53
5.3.1 GROWING AWARENESS ABOUT ANALYTICS IN VALUE AND PRECISION BASED CARE 53
5.3.2 INCREASE IN CLOUD BASED ANALYTICS 54
5.3.3 INCREASING IMPACT ON HEALTHCARE INDUSTRY DUE TO SOCIAL MEDIA 54
5.3.4 RISING PATIENT REGISTRIES 55
5.4 CHALLENGES 56
5.4.1 DATA CONFIDENTIALITY 56
5.4.2 ISSUES IN DATA ACCURACY AND CONSISTENCY 57
5.4.3 DATA INTEGRATION 57
5.4.4 FUNCTIONING GAP BETWEEN THE PROVIDERS AND PAYERS 57
6 GLOBAL HEALTHCARE ANALYTICS MARKET, BY TYPE 59
6.1 OVERVIEW 60
6.2 PRESCRIPTIVE ANALYTICS 62
6.3 PREDICTIVE ANALYTICS 63
6.4 DESCRIPTIVE ANALYTICS 64
7 GLOBAL HEALTHCARE ANALYTICS MARKET, BY COMPONENT 65
7.1 OVERVIEW 66
7.2 SERVICES 67
7.2.1 SUPPORT SERVICES 68
7.2.2 BUSINESS ANALYTICS SERVICES 68
7.3 SOFTWARE 69
7.4 HARDWARE 70
8 GLOBAL HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL 71
8.1 OVERVIEW 72
8.2 ON-DEMAND 73
8.3 ON-PREMISE 74
9 GLOBAL HEALTHCARE ANALYTICS MARKET, BY APPLICATION 75
9.1 OVERVIEW 76
9.2 CLINICAL ANALYTICS 78
9.2.1 REGULATORY REPORTING AND COMPLIANCE 79
9.2.2 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING 79
9.2.3 CLINICAL DECISION SUPPORT 79
9.2.4 COMPARATIVE ANALYTICS/ EFFECTIVENESS 79
9.2.5 PRECISION HEALTH 79
9.3 POPULATION HEALTH ANALYTICS 80
9.3.1 POPULATION CARE MANAGEMENT 81
9.3.2 POPULATION RISK MANAGEMENT 81
9.3.3 PATIENT ENGAGEMENT 81
9.3.4 CLINICAL OUTCOME MANAGEMENT 81
9.3.5 ACTIVITY-BASED COSTING 81
9.4 FINANCIAL ANALYTICS 82
9.4.1 PAYMENT INTEGRITY AND FRAUD, WASTE, AND ABUSE (FWA) 83
9.4.2 REVENUE CYCLE MANAGEMENT (RCM) 83
9.4.3 RISK ADJUSTMENT AND RISK ASSESSMENT 83
9.4.4 CLAIMS PROCESSING 83
9.5 OPERATIONAL AND ADMINISTRATIVE ANALYTICS 84
9.5.1 SUPPLY CHAIN ANALYTICS 85
9.5.2 WORKFORCE ANALYTICS 85
9.5.3 RESEARCH ANALYTICS 85
9.5.4 MARKET INTELLIGENCE 85
9.5.5 ENTERPRISE PERFORMANCE 85
9.5.6 STRATEGIC ANALYTICS 85
10 GLOBAL HEALTHCARE ANALYTICS MARKET, BY END USER 86
10.1 OVERVIEW 87
10.2 HEALTHCARE PAYERS 89
10.2.1 GOVERNMENT AGENCIES 90
10.2.2 PRIVATE INSURANCE COMPANIES 90
10.2.3 EMPLOYERS AND PRIVATE EXCHANGES 90
10.3 HEALTHCARE PROVIDERS 90
10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS 91
10.3.2 AMBULATORY SETTINGS 91
10.3.3 POST-ACUTE CARE ORGANIZATIONS 91
10.4 ACOS, HIES, MCOS AND TPAS 91
11 GLOBAL HEALTHCARE ANALYTICS MARKET, BY GEOGRAPHY 93
11.1 OVERVIEW 94
11.2 NORTH AMERICA 99
11.2.1 U.S. 109
11.2.2 CANADA 115
11.2.3 MEXICO 121
11.3 EUROPE 127
11.3.1 GERMANY 136
11.3.2 U.K. 142
11.3.3 FRANCE 148
11.3.4 SPAIN 154
11.3.5 ITALY 160
11.3.6 SWITZERLAND 166
11.3.7 NETHERLAND 172
11.3.8 TURKEY 178
11.3.9 BELGIUM 184
11.3.10 RUSSIA 190
11.3.11 REST OF EUROPE 196
11.4 ASIA-PACIFIC 197
11.4.1 JAPAN 206
11.4.2 CHINA 212
11.4.3 INDIA 218
11.4.4 SOUTH KOREA 224
11.4.5 AUSTRALIA 230
11.4.6 SINGAPORE 236
11.4.7 THAILAND 242
11.4.8 MALAYSIA 248
11.4.9 INDONESIA 254
11.4.10 PHILIPPINES 260
11.4.11 REST OF ASIA-PACIFIC 265
11.5 SOUTH AMERICA 266
11.5.1 BRAZIL 275
11.5.2 REST OF SOUTH AMERICA 281
11.6 MIDDLE EAST & AFRICA 282
11.6.1 SOUTH AFRICA 291
11.6.2 REST OF MIDDLE EAST & AFRICA 297
12 GLOBAL HEALTHCARE ANALYTICS MARKET, COMPANY LANDSCAPE 298
12.1 COMPANY SHARE ANALYSIS; GLOBAL 298
12.2 COMPANY SHARE ANALYSIS; NORTH AMERICA 299
12.3 COMPANY SHARE ANALYSIS; EUROPE 300
12.4 COMPANY SHARE ANALYSIS; ASIA-PACIFIC 301
13 COMPANY PROFILES 302
13.1 ALLSCRIPTS 302
13.1.1 COMPANY OVERVIEW 302
13.1.2 REVENUE ANALYSIS 302
13.1.3 PRODUCT PORTFOLIO 303
13.1.4 RECENT DEVELOPMENTS 305
13.2 OPTUM INC. 306
13.2.1 COMPANY OVERVIEW 306
13.2.2 GEOGRAPHICAL PRESENCE 306
13.2.3 PRODUCT PORTFOLIO 307
13.2.4 RECENT DEVELOPMENTS 311
?
13.3 ORACLE 312
13.3.1 COMPANY OVERVIEW 312
13.3.2 REVENUE ANALYSIS 312
13.3.3 PRODUCT PORTFOLIO 313
13.3.4 RECENT DEVELOPMENTS 313
13.4 CERNER 314
13.4.1 COMPANY OVERVIEW 314
13.4.2 REVENUE ANALYSIS 314
13.4.3 PRODUCT PORTFOLIO 315
13.4.4 RECENT DEVELOPMENTS 319
13.5 CITIUSTECH INC. 320
13.5.1 COMPANY OVERVIEW 320
13.5.2 GEOGRAPHICAL PRESENCE 320
13.5.3 PRODUCT PORTFOLIO 321
13.5.4 RECENT DEVELOPMENTS 321
13.6 WIPRO LIMITED 322
13.6.1 COMPANY SNAPSHOT 322
13.6.2 REVENUE ANALYSIS 322
13.6.3 PRODUCT PORTFOLIO 323
13.6.4 RECENT DEVELOPMENTS 323
13.7 VITREOSHEALTH 324
13.7.1 COMPANY SNAPSHOT 324
13.7.2 GEOGRAPHICAL PRESENCE 324
13.7.3 PRODUCT PORTFOLIO 325
13.7.4 RECENT DEVELOPMENTS 325
13.8 SCIO HEALTH ANALYTICS 326
13.8.1 COMPANY SNAPSHOT 326
13.8.2 PRODUCT PORTFOLIO 327
13.8.3 RECENT DEVELOPMENTS 327
13.9 HEALTHCARE CATALYST 329
13.9.1 COMPANY SNAPSHOT 329
13.9.2 GEOGRAPHICAL PRESENCE 329
13.9.3 PRODUCT PORTFOLIO 330
13.9.4 RECENT DEVELOPMENTS 332
13.10 GE HEALTHCARE 333
13.10.1 COMPANY SNAPSHOT 333
13.10.2 REVENUE ANALYSIS 333
13.10.3 PRODUCT PORTFOLIO 334
13.10.4 RECENT DEVELOPMENTS 335
?
13.11 IBM 336
13.11.1 COMPANY OVERVIEW 336
13.11.2 REVENUE ANALYSIS 336
13.11.3 PRODUCT PORTFOLIO 337
13.11.4 RECENT DEVELOPMENTS 338
13.12 INOVALON 338
13.12.1 COMPANY OVERVIEW 338
13.12.2 REVENUE ANALYSIS 338
13.12.3 PRODUCT PORTFOLIO 339
13.12.4 RECENT DEVELOPMENTS 340
13.13 VERSCEND TECHNOLOGIES INC. 341
13.13.1 COMPANY OVERVIEW 341
13.13.2 GEOGRAPHIC PRESENCE 341
13.13.3 PRODUCT PORTFOLIO 342
13.13.4 RECENT DEVELOPMENTS 343
13.14 MCKESSON CORPORATION 344
13.14.1 COMPANY SNAPSHOT 344
13.14.2 REVENUE ANALYSIS 344
13.14.3 PRODUCT PORTFOLIO 345
13.14.4 RECENT DEVELOPMENTS 346
13.15 SAS INSTITUTE 347
13.15.1 COMPANY OVERVIEW 347
13.15.2 REVENUE ANALYSIS 347
13.15.3 PRODUCT PORTFOLIO 348
13.15.4 RECENT DEVELOPMENTS 350
13.16 IKON-TECH 351
13.16.1 COMPANY OVERVIEW 351
13.16.2 PRODUCT PORTFOLIO 351
13.16.3 RECENT DEVELOPMENTS 351
13.17 IQVIA 352
13.17.1 COMPANY SNAPSHOT 352
13.17.2 REVENUE ANALYSIS 352
13.17.3 PRODUCT PORTFOLIO 353
13.17.4 RECENT DEVELOPMENTS 354
14 RELATED REPORTS 355